|
1
|
Morgan E, Arnold M, Gini A, Lorenzoni V,
Cabasag CJ, Laversanne M, Vignat J, Ferlay J, Murphy N and Bray F:
Global burden of colorectal cancer in 2020 and 2040: Incidence and
mortality estimates from GLOBOCAN. Gut. 72:338–344. 2023.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel RL, Giaquinto AN and Jemal A:
Cancer statistics, 2024. CA Cancer J Clin. 74:12–49. 2024.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Xi Y and Xu P: Global colorectal cancer
burden in 2020 and projections to 2040. Transl Oncol.
14:1011742021. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wong MC, Ding H, Wang J, Chan PS and Huang
J: Prevalence and risk factors of colorectal cancer in Asia. Intest
Res. 17:317–329. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Fearnhead NS, Wilding JL and Bodmer WF:
Genetics of colorectal cancer: Hereditary aspects and overview of
colorectal tumorigenesis. Br Med Bull. 64:27–43. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Stigliano V, Sanchez-Mete L, Martayan A
and Anti M: Early-onset colorectal cancer: A sporadic or inherited
disease? World J Gastroenterol. 20:124202014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kumar V, Abbas AK and Aster JC (eds):
Neoplasia. Robbins Basic Pathology. Elsevier; Philadelphia: pp.
185–240. 2023
|
|
8
|
Al-Sohaily S, Biankin A, Leong R,
Kohonen-Corish M and Warusavitarne J: Molecular pathways in
colorectal cancer. J Gastroenterol Hepatol. 27:1423–1431. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Medina Pabón MA and Babiker HM: A review
of hereditary colorectal cancers. StatPearls Publishing; Treasure
Island, FL: 2022
|
|
10
|
Saus E, Iraola-Guzmán S, Willis JR,
Brunet-Vega A and Gabaldón T: Microbiome and colorectal cancer:
Roles in carcinogenesis and clinical potential. Mol Aspects Med.
69:93–106. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wong SH and Yu J: Gut microbiota in
colorectal cancer: mechanisms of action and clinical applications.
Nat Rev Gastroenterol Hepatol. 16:690–704. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ocvirk S and O'Keefe SJD: Dietary fat,
bile acid metabolism and colorectal cancer. Semin Cancer Biol.
73:347–355. 2021. View Article : Google Scholar
|
|
13
|
Bernstein H and Bernstein C: Bile acids as
carcinogens in the colon and at other sites in the gastrointestinal
system. Exp Biol Med (Maywood). 248:79–89. 2023. View Article : Google Scholar
|
|
14
|
Rogers AC, Handelman GS, Solon JG,
McNamara DA, Deasy J and Burke JP: Meta-analysis of the
clinicopathological characteristics and peri-operative outcomes of
colorectal cancer in obese patients. Cancer Epidemiol. 51:23–29.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Liu PH, Wu K, Ng K, Zauber AG, Nguyen LH,
Song M, He X, Fuchs CS, Ogino S, Willett WC, et al: Association of
obesity with risk of early-onset colorectal cancer among women.
JAMA Oncol. 5:37–44. 2019. View Article : Google Scholar :
|
|
16
|
Li H, Boakye D, Chen X, Hoffmeister M and
Brenner H: Association of body mass index with risk of early-onset
colorectal cancer: Systematic review and meta-analysis. Am J
Gastroenterol. 116:2173–2183. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Suzuki S, Goto A, Nakatochi M, Narita A,
Yamaji T, Sawada N, Katagiri R, Iwagami M, Hanyuda A, Hachiya T, et
al: Body mass index and colorectal cancer risk: A Mendelian
randomization study. Cancer Sci. 112:1579–1588. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Cespedes Feliciano EM, Kroenke CH,
Meyerhardt JA, Prado CM, Bradshaw PT, Dannenberg AJ, Kwan ML, Xiao
J, Quesenberry C, Weltzien EK, et al: Metabolic dysfunction,
obesity, and survival among patients with early-stage colorectal
cancer. J Clin Oncol. 34:3664–3671. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Tilg H, Adolph TE, Gerner RR and Moschen
AR: The intestinal microbiota in colorectal cancer. Cancer Cell.
33:954–964. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Rezasoltani S, Asadzadeh Aghdaei H, Dabiri
H, Akhavan Sepahi A, Modarressi MH and Nazemalhosseini Mojarad E:
The association between fecal microbiota and different types of
colorectal polyp as precursors of colorectal cancer. Microb Pathog.
124:244–249. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Roje B, Zhang B, Mastrorilli E, Kovačić A,
Sušak L, Ljubenkov I, Ćosić E, Vilović K, Meštrović A, Vukovac EL,
et al: Gut microbiota carcinogen metabolism causes distal tissue
tumours. Nature. 632:1137–1144. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Lozenov S, Krastev B, Nikolaev G,
Peshevska-Sekulovska M, Peruhova M and Velikova T: Gut microbiome
composition and its metabolites are a key regulating factor for
malignant transformation, metastasis and antitumor immunity. Int J
Mol Sci. 24:59782023. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhang W, An Y, Qin X, Wu X, Wang X, Hou H,
Song X, Liu T, Wang B, Huang X and Cao H: Gut microbiota-derived
metabolites in colorectal cancer: The bad and the challenges. Front
Oncol. 11:7396482021. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Pavlova NN, Zhu J and Thompson CB: The
hallmarks of cancer metabolism: Still emerging. Cell Metab.
34:355–377. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Agathocleous M and Harris WA: Metabolism
in physiological cell proliferation and differentiation. Trends
Cell Biol. 23:484–492. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Pavlova NN and Thompson CB: The emerging
hallmarks of cancer metabolism. Cell Metab. 23:27–47. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Schiliro C and Firestein BL: Mechanisms of
metabolic reprogramming in cancer cells supporting enhanced growth
and proliferation. Cells. 10:10562021. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Brown RE, Short SP and Williams CS:
Colorectal cancer and metabolism. Curr Colorectal Cancer Rep.
14:226–241. 2018. View Article : Google Scholar
|
|
29
|
Suriya Muthukumaran N, Velusamy P, Akino
Mercy CS, Langford D, Natarajaseenivasan K and Shanmughapriya S:
MicroRNAs as regulators of cancer cell energy metabolism. J Pers
Med. 12:13292022. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Subramaniam S, Jeet V, Clements JA, Gunter
JH and Batra J: Emergence of MicroRNAs as key players in cancer
cell metabolism. Clin Chem. 65:1090–1101. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Hatziapostolou M, Polytarchou C and
Iliopoulos D: miRNAs link metabolic reprogramming to oncogenesis.
Trends Endocrinol Metab. 24:361–373. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Yuan C, Steer CJ and Subramanian S:
Host-MicroRNA-microbiota interactions in colorectal cancer. Genes
(Basel). 10:2702019. View Article : Google Scholar
|
|
33
|
Singh N, Shirdel EA, Waldron L, Zhang RH,
Jurisica I and Comelli EM: The murine caecal microRNA signature
depends on the presence of the endogenous microbiota. Int J Biol
Sci. 8:171–186. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zhong X, He X, Wang Y, Hu Z, Huang H, Zhao
S, Wei P and Li D: Warburg effect in colorectal cancer: the
emerging roles in tumor microenvironment and therapeutic
implications. J Hematol Oncol. 15:1602022. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Liberti MV and Locasale JW: The Warburg
effect: How does it benefit cancer cells? Trends Biochem Sci.
41:211–218. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Yang J, Wen J, Tian T, Lu Z, Wang Y, Wang
Z, Wang X and Yang Y: GLUT-1 overexpression as an unfavorable
prognostic biomarker in patients with colorectal cancer.
Oncotarget. 8:11788–11796. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Shen YM, Arbman G, Olsson B and Sun XF:
Overexpression of GLUT1 in colorectal cancer is independently
associated with poor prognosis. Int J Biol Markers. 26:166–172.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Chung FY, Huang MY, Yeh CS, Chang HJ,
Cheng TL, Yen LC, Wang JY and Lin SR: GLUT1 gene is a potential
hypoxic marker in colorectal cancer patients. BMC Cancer.
9:2412009. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Wang J, Ye C, Chen C, Xiong H, Xie B, Zhou
J, Chen Y, Zheng S and Wang L: Glucose transporter GLUT1 expression
and clinical outcome in solid tumors: A systematic review and
meta-analysis. Oncotarget. 8:16875–16886. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Feng W, Cui G, Tang CW, Zhang XL, Dai C,
Xu YQ, Gong H, Xue T, Guo HH and Bao Y: Role of glucose metabolism
related gene GLUT1 in the occurrence and prognosis of colorectal
cancer. Oncotarget. 8:56850–56857. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Ibrahiem AT, Refat S, Elnaghi K, Emarah Z
and Nagib RM: GLUT1 and ASCT2 expression and their prognostic value
in colorectal carcinoma. Indian J Pathol Microbiol. 67:518–524.
2024. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Ho N and Coomber BL: Hexokinase II
expression is correlated with colorectal cancer prognosis. Cancer
Treat Commun. 6:11–16. 2016. View Article : Google Scholar
|
|
43
|
He X, Lin X, Cai M, Zheng X, Lian L, Fan
D, Wu X, Lan P and Wang J: Overexpression of Hexokinase 1 as a poor
prognosticator in human colorectal cancer. Tumor Biol.
37:3887–3895. 2016. View Article : Google Scholar
|
|
44
|
Uppara M, Adaba F, Askari A, Clark S,
Hanna G, Athanasiou T and Faiz O: A systematic review and
meta-analysis of the diagnostic accuracy of pyruvate kinase M2
isoenzymatic assay in diagnosing colorectal cancer. World J Surg.
13:482015. View Article : Google Scholar
|
|
45
|
Wang J, Wang H, Liu A, Fang C, Hao J and
Wang Z: Lactate dehydrogenase A negatively regulated by miRNAs
promotes aerobic glycolysis and is increased in colorectal cancer.
Oncotarget. 6:19456–19468. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Koukourakis MI, Giatromanolaki A,
Simopoulos C, Polychronidis A and Sivridis E: Lactate dehydrogenase
5 (LDH5) relates to up-regulated hypoxia inducible factor pathway
and metastasis in colorectal cancer. Clin Exp Metastasis. 22:25–30.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Nakayama Y, Torigoe T, Inoue Y, Minagawa
N, Izumi H, Kohno K and Yamaguchi K: Prognostic significance of
monocarboxylate transporter 4 expression in patients with
colorectal cancer. Exp Ther Med. 3:25–30. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Pinheiro C, Longatto-Filho A, Scapulatempo
C, Ferreira L, Martins S, Pellerin L, Rodrigues M, Alves VA,
Schmitt F and Baltazar F: Increased expression of monocarboxylate
transporters 1, 2, and 4 in colorectal carcinomas. Virchows Archiv.
452:139–146. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Fang S and Fang X: Advances in glucose
metabolism research in colorectal cancer. Biomed Rep. 5:289–295.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Graziano F, Ruzzo A, Giacomini E,
Ricciardi T, Aprile G, Loupakis F, Lorenzini P, Ongaro E, Zoratto
F, Catalano V, et al: Glycolysis gene expression analysis and
selective metabolic advantage in the clinical progression of
colorectal cancer. Pharmacogenomics J. 17:258–264. 2017. View Article : Google Scholar
|
|
51
|
Wicks EE and Semenza GL: Hypoxia-inducible
factors: Cancer progression and clinical translation. J Clin
Invest. 132:e1598392022. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Denko NC: Hypoxia, HIF1 and glucose
metabolism in the solid tumour. Nat Rev Cancer. 8:705–713. 2008.
View Article : Google Scholar
|
|
53
|
Cao D, Hou M, Guan YS, Jiang M, Yang Y and
Gou HF: Expression of HIF-1alpha and VEGF in colorectal cancer:
Association with clinical outcomes and prognostic implications. BMC
Cancer. 9:4322009. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Baba Y, Nosho K, Shima K, Irahara N, Chan
AT, Meyerhardt JA, Chung DC, Giovannucci EL, Fuchs CS and Ogino S:
HIF1A overexpression is associated with poor prognosis in a cohort
of 731 colorectal cancers. Am J Pathol. 176:2292–2301. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Tang YA, Chen YF, Bao Y, Mahara S, Yatim
SMJM, Oguz G, Lee PL, Feng M, Cai Y, Tan EY, et al: Hypoxic tumor
microenvironment activates GLI2 via HIF-1α and TGF-β2 to promote
chemoresistance in colorectal cancer. Proc Natl Acad Sci USA.
115:E5990–E5999. 2018. View Article : Google Scholar
|
|
56
|
Leclerc D, Deng L, Trasler J and Rozen R:
ApcMin/+ mouse model of colon cancer: gene expression profiling in
tumors. J Cell Biochem. 93:1242–1254. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Cha PH, Hwang JH, Kwak DK, Koh E, Kim KS
and Choi KY: APC loss induces Warburg effect via increased PKM2
transcription in colorectal cancer. Br J Cancer. 124:634–644. 2021.
View Article : Google Scholar :
|
|
58
|
Zhang L and Shay JW: Multiple roles of APC
and its therapeutic implications in colorectal cancer. J Natl
Cancer Inst. 109:djw3322017. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Wang LB, Shen JG, Zhang SZ, Ding KF and
Zheng S: Amino acid uptake in arterio-venous serum of normal and
cancerous colon tissues. World J Gastroenterol. 10:12972004.
View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Ling HH, Pan YP, Fan CW, Tseng WK, Huang
JS, Wu TH, Chou WC, Wang CH, Yeh KY and Chang PH: Clinical
significance of serum glutamine level in patients with colorectal
cancer. Nutrients. 11:8982019. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Sun H, Zhang C, Zheng Y, Liu C, Wang X and
Cong X: Glutamine deficiency promotes recurrence and metastasis in
colorectal cancer through enhancing epithelial-mesenchymal
transition. J Transl Med. 20:3302022. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Song Z, Wei B, Lu C, Li P and Chen L:
Glutaminase sustains cell survival via the regulation of glycolysis
and glutaminolysis in colorectal cancer. Oncol Lett. 14:3117–3123.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Spada M, Piras C, Diana G, Leoni VP, Frau
DV, Serreli G, Simbula G, Loi R, Noto A, Murgia F, et al: Glutamine
starvation affects cell cycle, oxidative homeostasis and metabolism
in colorectal cancer cells. Antioxidants (Basel). 12:6832023.
View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Liu HY, Zhang HS, Liu MY, Li HM, Wang XY
and Wang M: GLS1 depletion inhibited colorectal cancer
proliferation and migration via redox/Nrf2/autophagy-dependent
pathway. Arch Biochem Biophys. 708:1089642021. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Miyo M, Konno M, Nishida N, Sueda T,
Noguchi K, Matsui H, Colvin H, Kawamoto K, Koseki J, Haraguchi N,
et al: Metabolic adaptation to nutritional stress in human
colorectal cancer. Sci Rep. 6:384152016. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Hoy AJ, Nagarajan SR and Butler LM: Tumour
fatty acid metabolism in the context of therapy resistance and
obesity. Nat Rev Cancer. 21:753–766. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Opie LH: Heart Physiology: From Cell to
Circulation. Lippincott Williams & Wilkins; pp. p6482004
|
|
68
|
Lopaschuk GD, Ussher JR, Folmes CD, Jaswal
JS and Stanley WC: Myocardial fatty acid metabolism in health and
disease. Physiol Rev. 90:207–258. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Baenke F, Peck B, Miess H and Schulze A:
Hooked on fat: The role of lipid synthesis in cancer metabolism and
tumour development. Dis Model Mech. 6:1353–1363. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Beloribi-Djefaflia S, Vasseur S and
Guillaumond F: Lipid metabolic reprogramming in cancer cells.
Oncogenesis. 5:e1892016. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Cohen S: Lipid droplets as organelles. Int
Rev Cell Mol Biol. 337:83–110. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Notarnicola M, Tutino V, Calvani M,
Lorusso D, Guerra V and Caruso MG: Serum levels of fatty acid
synthase in colorectal cancer patients are associated with tumor
stage. J Gastrointest Cancer. 43:508–511. 2012. View Article : Google Scholar
|
|
73
|
Zaytseva YY, Harris JW, Mitov MI, Kim JT,
Butterfield DA, Lee EY, Weiss HL, Gao T and Evers BM: Increased
expression of fatty acid synthase provides a survival advantage to
colorectal cancer cells via upregulation of cellular respiration.
Oncotarget. 6:18891–18904. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Drury J, Young LEA, Scott TL, Kelson CO,
He D, Liu J, Wu Y, Wang C, Weiss HL, Fan T, et al: Tissue-Specific
downregulation of fatty acid synthase suppresses intestinal adenoma
formation via coordinated reprograming of transcriptome and
metabolism in the mouse model of apc-driven colorectal cancer. Int
J Mol Sci. 23:65102022. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Mika A, Kobiela J, Czumaj A, Chmielewski
M, Stepnowski P and Sledzinski T: Hyper-elongation in colorectal
cancer tissue-cerotic acid is a potential novel serum metabolic
marker of colorectal malignancies. Cell Physiol Biochem.
41:722–730. 2017. View Article : Google Scholar
|
|
76
|
Rysman E, Brusselmans K, Scheys K,
Timmermans L, Derua R, Munck S, Van Veldhoven PP, Waltregny D,
Daniëls VW, Machiels J, et al: De novo lipogenesis protects cancer
cells from free radicals and chemotherapeutics by promoting
membrane lipid saturation. Cancer Res. 70:8117–8126. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Wen YA, Xiong X, Zaytseva YY, Napier DL,
Vallee E, Li AT, Wang C, Weiss HL, Evers BM and Gao T:
Downregulation of SREBP inhibits tumor growth and initiation by
altering cellular metabolism in colon cancer. Cell Death Dis.
9:2652018. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Wang H, Xi Q and Wu G: Fatty acid synthase
regulates invasion and metastasis of colorectal cancer via Wnt
signaling pathway. Cancer Med. 5:1599–1606. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Zaytseva YY, Rychahou PG, Gulhati P,
Elliott VA, Mustain WC, O'Connor K, Morris AJ, Sunkara M, Weiss HL,
Lee EY and Evers BM: Inhibition of fatty acid synthase attenuates
CD44-associated signaling and reduces metastasis in colorectal
cancer. Cancer Res. 72:1504–1517. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Sánchez-Martínez R, Cruz-Gil S, Gómez de
Cedrón M, Álvarez-Fernández M, Vargas T, Molina S, García B,
Herranz J, Moreno-Rubio J, Reglero G, et al: A link between lipid
metabolism and epithelial-mesenchymal transition provides a target
for colon cancer therapy. Oncotarget. 6:38719–38736. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Cruz-Gil S, Sanchez-Martinez R, Gomez de
Cedron M, Martin-Hernandez R, Vargas T, Molina S, Herranz J,
Davalos A, Reglero G and Ramirez de Molina A: Targeting the lipid
metabolic axis ACSL/SCD in colorectal cancer progression by
therapeutic miRNAs: miR-19b-1 role. J Lipid Res. 59:14–24. 2018.
View Article : Google Scholar :
|
|
82
|
Accioly MT, Pacheco P, Maya-Monteiro CM,
Carrossini N, Robbs BK, Oliveira SS, Kaufmann C, Morgado-Diaz JA,
Bozza PT and Viola JP: Lipid bodies are reservoirs of
cyclooxygenase-2 and sites of prostaglandin-E2 synthesis in colon
cancer cells. Cancer Res. 68:1732–1740. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Finetti F, Travelli C, Ercoli J, Colombo
G, Buoso E and Trabalzini L: Prostaglandin E2 and cancer: Insight
into tumor progression and immunity. Biology (Basel).
9:4342020.PubMed/NCBI
|
|
84
|
Cotte AK, Aires V, Fredon M, Limagne E,
Derangère V, Thibaudin M, Humblin E, Scagliarini A, de Barros JP,
Hillon P, et al: Lysophosphatidylcholine acyltransferase 2-mediated
lipid droplet production supports colorectal cancer
chemoresistance. Nat Commun. 9:3222018. View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Wang Y, Chen Y, Guan L, Zhang H, Huang Y,
Johnson CH, Wu Z, Gonzalez FJ, Yu A, Huang P, et al: Carnitine
palmitoyltransferase 1C regulates cancer cell senescence through
mitochondria-associated metabolic reprograming. Cell Death Differ.
25:735–748. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Li J, Zheng W, Wu J, Zhang J, Lv B, Li W,
Liu J, Zhang X, Huang T and Luo Z: CPT1C-mediated fatty acid
oxidation facilitates colorectal cancer cell proliferation and
metastasis. Acta Biochim Biophys Sin (Shanghai). 55:1301–1309.
2023.PubMed/NCBI
|
|
87
|
Fernández LP, Ramos-Ruiz R, Herranz J,
Martín-Hernández R, Vargas T, Mendiola M, Guerra L, Reglero G,
Feliu J and Ramírez de Molina A: The transcriptional and mutational
landscapes of lipid metabolism-related genes in colon cancer.
Oncotarget. 9:5919–5930. 2017. View Article : Google Scholar
|
|
88
|
Vannini I, Fanini F and Fabbri M: Emerging
roles of microRNAs in cancer. Curr Opin Genet Dev. 48:128–133.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
89
|
Ali Syeda Z, Langden SSS, Munkhzul C, Lee
M and Song SJ: Regulatory mechanism of MicroRNA expression in
cancer. Int J Mol Sci. 21:17232020. View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Lin S and Gregory RI: MicroRNA biogenesis
pathways in cancer. Nat Rev Cancer. 15:321–333. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
91
|
Quirico L, Orso F, Cucinelli S, Paradzik
M, Natalini D, Centonze G, Dalmasso A, La Vecchia S, Coco M,
Audrito V, et al: miRNA-guided reprogramming of glucose and
glutamine metabolism and its impact on cell adhesion/migration
during solid tumor progression. Cell Mol Life Sci. 79:2162022.
View Article : Google Scholar : PubMed/NCBI
|
|
92
|
Li W, Lu Y, Ye C and Ouyang M: The
regulatory network of MicroRNA in the metabolism of colorectal
cancer. J Cancer. 12:7454–7464. 2021. View Article : Google Scholar
|
|
93
|
Jin Y, Wang M, Hu H, Huang Q, Chen Y and
Wang G: Overcoming stemness and chemoresistance in colorectal
cancer through miR-195-5p-modulated inhibition of notch signaling.
Int J Biol Macromol. 117:445–453. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
94
|
Fei X, Qi M, Wu B, Song Y, Wang Y and Li
T: MicroRNA-195-5p suppresses glucose uptake and proliferation of
human bladder cancer T24 cells by regulating GLUT3 expression. FEBS
Lett. 586:392–397. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
95
|
Dai W, Xu Y, Mo S, Li Q, Yu J, Wang R, Ma
Y, Ni Y, Xiang W, Han L, et al: GLUT3 induced by AMPK/CREB1 axis is
key for withstanding energy stress and augments the efficacy of
current colorectal cancer therapies. Signal Transduct Target Ther.
5:1772020. View Article : Google Scholar : PubMed/NCBI
|
|
96
|
Santasusagna S, Moreno I, Navarro A, Muñoz
C, Martinez F, Hernández R, Castellano JJ and Monzo M: miR-328
mediates a metabolic shift in colon cancer cells by targeting
SLC2A1/GLUT1. Clin Transl Oncol. 20:1161–1167. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
97
|
Schwartz L, T Supuran C and Alfarouk KO:
The Warburg effect and the hallmarks of cancer. Anticancer Agents
Med Chem. 17:164–170. 2017. View Article : Google Scholar
|
|
98
|
Gregersen LH, Jacobsen A, Frankel LB, Wen
J, Krogh A and Lund AH: MicroRNA-143 down-regulates Hexokinase 2 in
colon cancer cells. BMC Cancer. 12:2322012. View Article : Google Scholar : PubMed/NCBI
|
|
99
|
Michael MZ, O'Connor SM, van Holst
Pellekaan NG, Young GP and James RJ: Reduced accumulation of
specific microRNAs in colorectal neoplasia. Mol Cancer Res.
1:882–891. 2003.PubMed/NCBI
|
|
100
|
Chen X, Guo X, Zhang H, Xiang Y, Chen J,
Yin Y, Cai X, Wang K, Wang G, Ba Y, et al: Role of miR-143
targeting KRAS in colorectal tumorigenesis. Oncogene. 28:1385–1392.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
101
|
Slabý O, Svoboda M, Fabian P, Svoboda M,
Garajova I, Šachlova M, Šmerdova T, Knoflickova D and Vyzula R:
Association of miR-21, miR-31, miR-143, miR-145 and let-7a-1 levels
with histopathologic features of colorectal cancer. Eur J Cancer.
5:78–79. 2007. View Article : Google Scholar
|
|
102
|
Sun Y, Zhao X, Zhou Y and Hu Y: miR-124,
miR-137 and miR-340 regulate colorectal cancer growth via
inhibition of the Warburg effect. Oncol Rep. 28:1346–1352. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
103
|
Puckett DL, Alquraishi M, Chowanadisai W
and Bettaieb A: The role of PKM2 in metabolic reprogramming:
Insights into the regulatory roles of non-coding RNAs. Int J Mol
Sci. 22:11712021. View Article : Google Scholar : PubMed/NCBI
|
|
104
|
Petrelli F, Cabiddu M, Coinu A, Borgonovo
K, Ghilardi M, Lonati V and Barni S: Prognostic role of lactate
dehydrogenase in solid tumors: A systematic review and
meta-analysis of 76 studies. Acta Oncol. 54:961–970. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
105
|
Chang TC, Wentzel EA, Kent OA,
Ramachandran K, Mullendore M, Lee KH, Feldmann G, Yamakuchi M,
Ferlito M, Lowenstein CJ, et al: Transactivation of miR-34a by p53
broadly influences gene expression and promotes apoptosis. Mol
Cell. 26:745–752. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
106
|
Kim NH, Kim HS, Li XY, Lee I, Choi HS,
Kang SE, Cha SY, Ryu JK, Yoon D, Fearon ER, et al: A p53/miRNA-34
axis regulates Snail1-dependent cancer cell epithelial-mesenchymal
transition. J Cell Biol. 195:417–433. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
107
|
Kim NH, Kim HS, Kim NG, Lee I, Choi HS, Li
XY, Kang SE, Cha SY, Ryu JK, Na JM, et al: p53 and microRNA-34 are
suppressors of canonical Wnt signaling. Sci Signal. 4:ra712011.
View Article : Google Scholar : PubMed/NCBI
|
|
108
|
Chen B, Liu Y, Jin X, Lu W, Liu J, Xia Z,
Yuan Q, Zhao X, Xu N and Liang S: MicroRNA-26a regulates glucose
metabolism by direct targeting PDHX in colorectal cancer cells. BMC
Cancer. 14:4432014. View Article : Google Scholar : PubMed/NCBI
|
|
109
|
Volinia S, Calin GA, Liu CG, Ambs S,
Cimmino A, Petrocca F, Visone R, Iorio M, Roldo C, Ferracin M, et
al: A microRNA expression signature of human solid tumors defines
cancer gene targets. Proc Natl Acad Sci USA. 103:2257–2261. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
110
|
Huse JT, Brennan C, Hambardzumyan D, et
al: The PTEN-regulating microRNA miR-26a is amplified in high-grade
glioma and facilitates gliomagenesis in vivo. Genes Dev.
23:1327–1337. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
111
|
Dong J, Xiao D, Zhao Z, Ren P, Li C, Hu Y,
Shi J, Su H, Wang L, Liu H, et al: Epigenetic silencing of
microRNA-137 enhances ASCT2 expression and tumor glutamine
metabolism. Oncogenesis. 6:e3562017. View Article : Google Scholar : PubMed/NCBI
|
|
112
|
Balaguer F, Link A, Lozano JJ, Cuatrecasas
M, Nagasaka T, Boland CR and Goel A: Epigenetic silencing of
miR-137 is an early event in colorectal carcinogenesis. Cancer Res.
70:6609–6618. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
113
|
Venkateswaran N, Lafita-Navarro MC, Hao
YH, Kilgore JA, Perez-Castro L, Braverman J, Borenstein-Auerbach N,
Kim M, Lesner NP, Mishra P, et al: MYC promotes tryptophan uptake
and metabolism by the kynurenine pathway in colon cancer. Genes
Dev. 33:1236–1251. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
114
|
Gao P, Tchernyshyov I, Chang TC, Lee YS,
Kita K, Ochi T, Zeller KI, De Marzo AM, Van Eyk JE, Mendell JT and
Dang CV: c-Myc suppression of miR-23a/b enhances mitochondrial
glutaminase expression and glutamine metabolism. Nature.
458:762–765. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
115
|
Wang Z, Wei W and Sarkar FH: miR-23a, a
critical regulator of 'migR' ation and metastasis in colorectal
cancer. Cancer Discov. 2:489–491. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
116
|
Deng YH, Deng ZH, Hao H, Wu XL, Gao H,
Tang SH and Tang H: MicroRNA-23a promotes colorectal cancer cell
survival by targeting PDK4. Exp Cell Res. 373:171–179. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
117
|
Sengupta D, Cassel T, Teng KY, Aljuhani M,
Chowdhary VK, Hu P, Zhang X, Fan TW and Ghoshal K: Regulation of
hepatic glutamine metabolism by miR-122. Mol Metab. 34:174–186.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
118
|
Wong CC, Qian Y, Li X, Xu J, Kang W, Tong
JH, To KF, Jin Y, Li W, Chen H, et al: SLC25A22 promotes
proliferation and survival of colorectal cancer cells with KRAS
mutations and xenograft tumor progression in mice via intracellular
synthesis of aspartate. Gastroenterology. 151:945–960.e6. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
119
|
Dinu D, Dobre M, Panaitescu E, Bîrlă R,
Iosif C, Hoara P, Caragui A, Boeriu M, Constantinoiu S and
Ardeleanu C: Prognostic significance of KRAS gene mutations in
colorectal cancer-preliminary study. J Med Life. 7:581–587.
2014.
|
|
120
|
Hatley ME, Patrick DM, Garcia MR,
Richardson JA, Bassel-Duby R, van Rooij E and Olson EN: Modulation
of K-Ras-dependent lung tumorigenesis by MicroRNA-21. Cancer Cell.
18:282–293. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
121
|
You C, Jin L, Xu Q, Shen B, Jiao X and
Huang X: Expression of miR-21 and miR-138 in colon cancer and its
effect on cell proliferation and prognosis. Oncol Lett.
17:2271–2277. 2019.PubMed/NCBI
|
|
122
|
Carvalho TI, Novais PC, Lizarte FS, Neto,
Sicchieri RD, Rosa MS, Carvalho CA, Tirapelli DP, Peria FM, Rocha
JJ and Féres O: Analysis of gene expression EGFR and KRAS,
microRNA-21 and microRNA-203 in patients with colon and rectal
cancer and correlation with clinical outcome and prognostic
factors1. Acta Cir Bras. 32:243–250. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
123
|
Hao Y, Samuels Y, Li Q, Krokowski D, Guan
BJ, Wang C, Jin Z, Dong B, Cao B, Feng X, et al: Oncogenic PIK3CA
mutations reprogram glutamine metabolism in colorectal cancer. Nat
Commun. 7:119712016. View Article : Google Scholar : PubMed/NCBI
|
|
124
|
Zhao Y, Zhao X, Chen V, Feng Y, Wang L,
Croniger C, Conlon RA, Markowitz S, Fearon E, Puchowicz M, et al:
Colorectal cancers utilize glutamine as an anaplerotic substrate of
the TCA cycle in vivo. Sci Rep. 9:191802019. View Article : Google Scholar : PubMed/NCBI
|
|
125
|
Wang Y, Tang Q, Li M, Jiang S and Wang X:
MicroRNA-375 inhibits colorectal cancer growth by targeting PIK3CA.
Biochem Biophys Res Commun. 444:199–204. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
126
|
Iino I, Kikuchi H, Miyazaki S, Hiramatsu
Y, Ohta M, Kamiya K, Kusama Y, Baba S, Setou M and Konno H: Effect
of mi R-122 and its target gene cationic amino acid transporter 1
on colorectal liver metastasis. Cancer Sci. 104:624–630. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
127
|
Sun L, Liu X, Pan B, Hu X, Zhu Y, Su Y,
Guo Z, Zhang G, Xu M, Xu X, et al: Serum exosomal miR-122 as a
potential diagnostic and prognostic biomarker of colorectal cancer
with liver metastasis. J Cancer. 11:630–637. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
128
|
Maierthaler M, Benner A, Hoffmeister M,
Surowy H, Jansen L, Knebel P, Chang-Claude J, Brenner H and
Burwinkel B: Plasma miR-122 and miR-200 family are prognostic
markers in colorectal cancer. Int J Cancer. 140:176–187. 2017.
View Article : Google Scholar
|
|
129
|
Sendi H, Yazdimamaghani M, Hu M,
Sultanpuram N, Wang J, Moody AS, McCabe E, Zhang J, Graboski A, Li
L, et al: Nanoparticle delivery of miR-122 inhibits colorectal
cancer liver metastasis. Cancer Res. 82:105–113. 2022. View Article : Google Scholar :
|
|
130
|
Coulouarn C, Factor VM, Andersen JB,
Durkin ME and Thorgeirsson SS: Loss of miR-122 expression in liver
cancer correlates with suppression of the hepatic phenotype and
gain of metastatic properties. Oncogene. 28:3526–3536. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
131
|
Krützfeldt J, Rajewsky N, Braich R, Rajeev
KG, Tuschl T, Manoharan M and Stoffel M: Silencing of microRNAs in
vivo with 'antagomirs'. Nature. 438:685–689. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
132
|
Esau C, Davis S, Murray SF, Yu XX, Pandey
SK, Pear M, Watts L, Booten SL, Graham M, McKay R, et al: miR-122
regulation of lipid metabolism revealed by in vivo antisense
targeting. Cell Metab. 3:87–98. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
133
|
Gharib E, Nasri Nasrabadi P and Reza Zali
M: miR-497-5p mediates starvation-induced death in colon cancer
cells by targeting acyl-CoA synthetase-5 and modulation of lipid
metabolism. J Cell Physiol. 235:5570–5589. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
134
|
Hou K, Wu ZX, Chen XY, Wang JQ, Zhang D,
Xiao C, Zhu D, Koya JB, Wei L, Li J and Chen ZS: Microbiota in
health and diseases. Signal Transduct Target Ther. 7:1352022.
View Article : Google Scholar : PubMed/NCBI
|
|
135
|
El Kaoutari A, Armougom F, Gordon JI,
Raoult D and Henrissat B: The abundance and variety of
carbohydrate-active enzymes in the human gut microbiota. Nat Rev
Microbiol. 11:497–504. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
136
|
Porter HA, Perry A, Kingsley C, Tran NL
and Keegan AD: IRS1 is highly expressed in localized breast tumors
and regulates the sensitivity of breast cancer cells to
chemotherapy, while IRS2 is highly expressed in invasive breast
tumors. Cancer Lett. 338:239–248. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
137
|
Litvak Y, Byndloss MX and Bäumler AJ:
Colonocyte metabolism shapes the gut microbiota. Science.
362:eaat90762018. View Article : Google Scholar : PubMed/NCBI
|
|
138
|
Yuan C, Burns MB, Subramanian S and
Blekhman R: Interaction between host MicroRNAs and the gut
microbiota in colorectal cancer. MSystems. 3:00205–17. 2018.
View Article : Google Scholar
|
|
139
|
Abed J, Emgård JE, Zamir G, Faroja M,
Almogy G, Grenov A, Sol A, Naor R, Pikarsky E, Atlan KA, et al:
Fap2 mediates Fusobacterium nucleatum colorectal adenocarcinoma
enrichment by binding to tumor-expressed Gal-GalNAc. Cell Host
Microbe. 20:215–225. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
140
|
Tailford LE, Crost EH, Kavanaugh D and
Juge N: Mucin glycan foraging in the human gut microbiome. Front
Genet. 6:812015. View Article : Google Scholar : PubMed/NCBI
|
|
141
|
Feng YY, Zeng DZ, Tong YN, Lu XX, Dun GD,
Tang B, Zhang ZJ, Ye XL, Li Q, Xie JP and Mao XH: Alteration of
microRNA-4474/4717 expression and CREB-binding protein in human
colorectal cancer tissues infected with Fusobacterium nucleatum.
PLoS One. 14:e02150882019. View Article : Google Scholar : PubMed/NCBI
|
|
142
|
Fauquier L, Azzag K, Parra MAM, Quillien
A, Boulet M, Diouf S, Carnac G, Waltzer L, Gronemeyer H and Vandel
L: CBP and P300 regulate distinct gene networks required for human
primary myoblast differentiation and muscle integrity. Sci Rep.
8:126292018. View Article : Google Scholar : PubMed/NCBI
|
|
143
|
Martins VF, LaBarge SA, Stanley A,
Svensson K, Hung CW, Keinan O, Ciaraldi TP, Banoian D, Park JE, Ha
C, et al: p300 or CBP is required for insulin-stimulated glucose
uptake in skeletal muscle and adipocytes. JCI insight.
7:e1413442022. View Article : Google Scholar :
|
|
144
|
De Reuse H and Skouloubris S: Nitrogen
metabolism. Helicobacter pylori: Physiology and Genetics. Mobley
HLT, Mendz GL and Hazell SL: ASM Press; Washington, DC: pp.
125–133. 2001
|
|
145
|
Ternes D, Tsenkova M, Pozdeev VI, Meyers
M, Koncina E, Atatri S, Schmitz M, Karta J, Schmoetten M, Heinken
A, et al: The gut microbial metabolite formate exacerbates
colorectal cancer progression. Nat Metab. 4:458–475. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
146
|
Chaushu S, Wilensky A, Gur C, Shapira L,
Elboim M, Halftek G, Polak D, Achdout H, Bachrach G and Mandelboim
O: Direct recognition of Fusobacterium nucleatum by the NK cell
natural cytotoxicity receptor NKp46 aggravates periodontal disease.
PLoS Pathog. 8:e10026012012. View Article : Google Scholar : PubMed/NCBI
|
|
147
|
Chang X, Zhu W, Zhang H and Lian S:
Sensitization of melanoma cells to temozolomide by overexpression
of microRNA 203 through direct targeting of glutaminase-mediated
glutamine metabolism. Clin Exp Dermatol. 42:614–621. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
148
|
Xing J, Liao Y, Zhang H, Zhang W, Zhang Z,
Zhang J, Wang D and Tang D: Impacts of MicroRNAs induced by the gut
microbiome on regulating the development of colorectal cancer.
Front Cell Infect Microbiol. 12:8046892022. View Article : Google Scholar : PubMed/NCBI
|
|
149
|
Heydari Z, Rahaie M, Alizadeh AM, Agah S,
Khalighfard S and Bahmani S: Effects of Lactobacillus acidophilus
and Bifidobacterium bifidum probiotics on the expression of
microRNAs 135b, 26b, 18a and 155, and their involving genes in mice
colon cancer. Probiotics Antimicrob Proteins. 11:1155–1162. 2019.
View Article : Google Scholar
|
|
150
|
Anderton B, Camarda R, Balakrishnan S,
Balakrishnan A, Kohnz RA, Lim L, Evason KJ, Momcilovic O, Kruttwig
K, Huang Q, et al: MYC-driven inhibition of the glutamate-cysteine
ligase promotes glutathione depletion in liver cancer. EMBO Rep.
18:569–585. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
151
|
Wu M, Xiao H, Liu G, Chen S, Tan B, Ren W,
Bazer FW, Wu G and Yin Y: Glutamine promotes intestinal SIgA
secretion through intestinal microbiota and IL-13. Mol Nutr Food
Res. 60:1637–1648. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
152
|
Liu G, Ren W, Fang J, Hu CA, Guan G,
Al-Dhabi NA, Yin J, Duraipandiyan V, Chen S, Peng Y and Yin Y:
L-Glutamine and L-arginine protect against enterotoxigenic
Escherichia coli infection via intestinal innate immunity in mice.
Amino Acids. 49:1945–1954. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
153
|
Palomo-Buitrago ME, Sabater-Masdeu M,
Moreno-Navarrete JM, Caballano-Infantes E, Arnoriaga-Rodríguez M,
Coll C, Ramió L, Palomino-Schätzlein M, Gutiérrez-Carcedo P,
Pérez-Brocal V, et al: Glutamate interactions with obesity, insulin
resistance, cognition and gut microbiota composition. Acta
Diabetol. 56:569–579. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
154
|
Fang CY, Chen JS, Hsu BM, Hussain B,
Rathod J and Lee KH: Colorectal cancer stage-specific fecal
bacterial community fingerprinting of the Taiwanese population and
underpinning of potential taxonomic biomarkers. Microorganisms.
9:15482021. View Article : Google Scholar : PubMed/NCBI
|
|
155
|
Zhou Q, Souba WW, Croce CM and Verne GN:
MicroRNA-29a regulates intestinal membrane permeability in patients
with irritable bowel syndrome. Gut. 59:775–784. 2010. View Article : Google Scholar
|
|
156
|
Yang YL, Huang YH, Wang FS, Tsai MC, Chen
CH and Lian WS: MicroRNA-29a compromises hepatic adiposis and gut
dysbiosis in high fat diet-fed mice via downregulating
inflammation. Mol Nutr Food Res. 67:22003482023. View Article : Google Scholar
|
|
157
|
Virtue AT, McCright SJ, Wright JM, Jimenez
MT, Mowel WK, Kotzin JJ, Joannas L, Basavappa MG, Spencer SP, Clark
ML, et al: The gut microbiota regulates white adipose tissue
inflammation and obesity via a family of microRNAs. Sci Transl Med.
11:eaav18922019. View Article : Google Scholar : PubMed/NCBI
|
|
158
|
Wikoff WR, Anfora AT, Liu J, Schultz PG,
Lesley SA, Peters EC and Siuzdak G: Metabolomics analysis reveals
large effects of gut microflora on mammalian blood metabolites.
Proc Natl Acad Sci USA. 106:3698–3703. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
159
|
Fan P, Li L, Rezaei A, Eslamfam S, Che D
and Ma X: Metabolites of dietary protein and peptides by intestinal
microbes and their impacts on gut. Curr Protein Pept Sci.
16:646–654. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
160
|
Ma N, Tian Y, Wu Y and Ma X: Contributions
of the interaction between dietary protein and gut microbiota to
intestinal health. Curr Protein Pept Sci. 18:795–808. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
161
|
den Besten G, Lange K, Havinga R, van Dijk
TH, Gerding A, van Eunen K, Müller M, Groen AK, Hooiveld GJ, Bakker
BM and Reijngoud DJ: Gut-derived short-chain fatty acids are
vividly assimilated into host carbohydrates and lipids. Am J
Physiol Gastrointest Liver Physiol. 305:G900–G910. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
162
|
Brahe LK, Astrup A and Larsen LH: Is
butyrate the link between diet, intestinal microbiota and
obesity-related metabolic diseases? Obes Rev. 14:950–959. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
163
|
Cummings JH, Pomare EW, Branch WJ, Naylor
CP and MacFarlane GT: Short chain fatty acids in human large
intestine, portal, hepatic and venous blood. Gut. 28:1221–1227.
1987. View Article : Google Scholar : PubMed/NCBI
|
|
164
|
Haenen D, Zhang J, Souza da Silva C, Bosch
G, van der Meer IM, van Arkel J, van den Borne JJ, Pérez Gutiérrez
O, Smidt H, Kemp B, et al: A diet high in resistant starch
modulates microbiota composition, SCFA concentrations, and gene
expression in pig intestine. J Nutr. 143:274–283. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
165
|
Birt DF, Boylston T, Hendrich S, Jane JL,
Hollis J, Li L, McClelland J, Moore S, Phillips GJ, Rowling M, et
al: Resistant starch: promise for improving human health. Adv Nutr.
4:587–601. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
166
|
Liu H, Wang J, He T, Becker S, Zhang G, Li
D and Ma X: Butyrate: A double-edged sword for health? Adv Nutr.
9:21–29. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
167
|
Zhu W, Peng K, Zhao Y, Xu C, Tao X, Liu Y,
Huang Y and Yang X: Sodium butyrate attenuated diet-induced
obesity, insulin resistance and inflammation partly by promoting
fat thermogenesis via intro-adipose sympathetic innervation. Front
Pharmacol. 13:9387602022. View Article : Google Scholar : PubMed/NCBI
|
|
168
|
McNabney SM and Henagan TM: Short chain
fatty acids in the colon and peripheral tissues: A focus on
butyrate, colon cancer, obesity and insulin resistance. Nutrients.
9:13482017. View Article : Google Scholar : PubMed/NCBI
|
|
169
|
Den Besten G, Bleeker A, Gerding A, van
Eunen K, Havinga R, van Dijk TH, Oosterveer MH, Jonker JW, Groen
AK, Reijngoud DJ and Bakker BM: Short-chain fatty acids protect
against high-fat diet–induced obesity via a PPARγ-dependent switch
from lipogenesis to fat oxidation. Diabetes. 64:2398–2408. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
170
|
Gao Z, Yin J, Zhang J, Ward RE, Martin RJ,
Lefevre M, Cefalu WT and Ye J: Butyrate improves insulin
sensitivity and increases energy expenditure in mice. Diabetes.
58:1509–1517. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
171
|
Donohoe CL, Doyle SL and Reynolds JV:
Visceral adiposity, insulin resistance and cancer risk. Diabetol
Metab Syndr. 3:122011. View Article : Google Scholar : PubMed/NCBI
|
|
172
|
Hanus M, Parada-Venegas D, Landskron G,
Wielandt AM, Hurtado C, Alvarez K, Hermoso MA, López-Köstner F and
De la Fuente M: Immune system, microbiota, and microbial
metabolites: The unresolved triad in colorectal cancer
microenvironment. Front Immunol. 12:6128262021. View Article : Google Scholar : PubMed/NCBI
|
|
173
|
Mirzaei R, Afaghi A, Babakhani S, Sohrabi
MR, Hosseini-Fard SR, Babolhavaeji K, Khani Ali Akbari S,
Yousefimashouf R and Karampoor S: Role of microbiota-derived
short-chain fatty acids in cancer development and prevention.
Biomed Pharmacother. 139:1116192021. View Article : Google Scholar : PubMed/NCBI
|
|
174
|
Okumura S, Konishi Y, Narukawa M, Sugiura
Y, Yoshimoto S, Arai Y, Sato S, Yoshida Y, Tsuji S, Uemura K, et
al: Gut bacteria identified in colorectal cancer patients promote
tumourigenesis via butyrate secretion. Nat Commun. 12:56742021.
View Article : Google Scholar : PubMed/NCBI
|
|
175
|
Bultman SJ: Molecular pathways:
Gene-environment interactions regulating dietary fiber induction of
proliferation and apoptosis via butyrate for cancer prevention.
Clin Cancer Res. 20:799–803. 2014. View Article : Google Scholar :
|
|
176
|
Louis P, Hold GL and Flint HJ: The gut
microbiota, bacterial metabolites and colorectal cancer. Nat Rev
Microbiol. 12:661–672. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
177
|
Hu S, Dong TS, Dalal SR, Wu F, Bissonnette
M, Kwon JH and Chang EB: The microbe-derived short chain fatty acid
butyrate targets miRNA-dependent p21 gene expression in human colon
cancer. PLoS One. 6:e162212011. View Article : Google Scholar : PubMed/NCBI
|
|
178
|
Hu S, Liu L, Chang EB, Wang JY and Raufman
JP: Butyrate inhibits pro-proliferative miR-92a by diminishing
c-Myc-induced miR-17-92a cluster transcription in human colon
cancer cells. Mol Cancer. 14:1802015. View Article : Google Scholar : PubMed/NCBI
|
|
179
|
Balacescu O, Sur D, Cainap C, Visan S,
Cruceriu D, Manzat-Saplacan R, Muresan MS, Balacescu L, Lisencu C
and Irimie A: The impact of miRNA in colorectal cancer progression
and its liver metastases. Int J Mol Sci. 19:37112018. View Article : Google Scholar : PubMed/NCBI
|
|
180
|
Asadi M, Talesh ST, Gjerstorff MF,
Shanehbandi D, Baradaran B, Hashemzadeh S and Zafari V:
Identification of miRNAs correlating with stage and progression of
colorectal cancer. Colorectal Cancer. 8:CRC062019. View Article : Google Scholar
|
|
181
|
Strubberg AM and Madison BB: MicroRNAs in
the etiology of colorectal cancer: Pathways and clinical
implications. Dis Model Mech. 10:197–214. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
182
|
Bahnassy AA, El-Sayed M, Ali NM, Khorshid
O, Hussein MM, Yousef HF, Mohanad MA, Zekri ARN and Salem SE:
Aberrant expression of miRNAs predicts recurrence and survival in
stage-II colorectal cancer patients from Egypt. Appl Cancer Res.
37:392017. View Article : Google Scholar
|
|
183
|
Qian J, Zeng L, Jiang X, Zhang Z and Luo
X: Novel multiple miRNA-based signatures for predicting overall
survival and recurrence-free survival of colorectal cancer
patients. Med Sci Monit. 25:7258–7271. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
184
|
Koga Y, Yasunaga M, Takahashi A, Kuroda J,
Moriya Y, Akasu T, Fujita S, Yamamoto S, Baba H and Matsumura Y:
MicroRNA expression profiling of exfoliated colonocytes isolated
from feces for colorectal cancer screening. Cancer Prev Res
(Phila). 3:1435–1442. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
185
|
Yau TO, Wu CW, Dong Y, Tang CM, Ng SS,
Chan FK, Sung JJ and Yu J: microRNA-221 and microRNA-18a
identification in stool as potential biomarkers for the
non-invasive diagnosis of colorectal carcinoma. Br J Cancer.
111:1765–1771. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
186
|
Wu CW, Ng SC, Dong Y, Tian L, Ng SS, Leung
WW, Law WT, Yau TO, Chan FK, Sung JJ and Yu J: Identification of
microRNA-135b in stool as a potential noninvasive biomarker for
colorectal cancer and adenoma. Clin Cancer Res. 20:2994–3002. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
187
|
Li L, Wang A, Cai M, Tong M, Chen F and
Huang L: Identification of stool miR-135b-5p as a non-invasive
diaognostic biomarker in later tumor stage of colorectal cancer.
Life Sci. 260:1184172020. View Article : Google Scholar : PubMed/NCBI
|
|
188
|
Yau TO, Wu CW, Tang CM, Chen Y, Fang J,
Dong Y, Liang Q, Ng SS, Chan FK, Sung JJ and Yu J: MicroRNA-20a in
human faeces as a non-invasive biomarker for colorectal cancer.
Oncotarget. 7:1559–1568. 2016. View Article : Google Scholar :
|
|
189
|
Choi HH, Cho YS, Choi JH, Kim HK, Kim SS
and Chae HS: Stool-Based miR-92a and miR-144* as noninvasive
biomarkers for colorectal cancer screening. Oncology. 97:173–179.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
190
|
Wu CW, Ng SS, Dong YJ, Ng SC, Leung WW,
Lee CW, Wong YN, Chan FK, Yu J and Sung JJ: Detection of miR-92a
and miR-21 in stool samples as potential screening biomarkers for
colorectal cancer and polyps. Gut. 61:739–745. 2012. View Article : Google Scholar
|
|
191
|
Chang PY, Chen CC, Chang YS, Tsai WS, You
JF, Lin GP, Chen TW, Chen JS and Chan EC: MicroRNA-223 and
microRNA-92a in stool and plasma samples act as complementary
biomarkers to increase colorectal cancer detection. Oncotarget.
7:10663–10675. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
192
|
Koga Y, Yamazaki N, Yamamoto Y, Yamamoto
S, Saito N, Kakugawa Y, Otake Y, Matsumoto M and Matsumura Y: Fecal
miR-106a is a useful marker for colorectal cancer patients with
false-negative results in immunochemical fecal occult blood test.
Cancer Epidemiol Biomarkers Prev. 22:1844–1852. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
193
|
Duran-Sanchon S, Moreno L, Augé JM,
Serra-Burriel M, Cuatrecasas M, Moreira L, Martín A, Serradesanferm
A, Pozo À, Costa R, et al: Identification and validation of
microRNA profiles in fecal samples for detection of colorectal
cancer. Gastroenterology. 158:947–957.e4. 2020. View Article : Google Scholar
|
|
194
|
Tarallo S, Ferrero G, Gallo G, Francavilla
A, Clerico G, Realis Luc A, Manghi P, Thomas AM, Vineis P, Segata
N, et al: Altered fecal small RNA profiles in colorectal cancer
reflect gut microbiome composition in stool samples. mSystems.
4:e00289–19. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
195
|
Link A, Balaguer F, Shen Y, Nagasaka T,
Lozano JJ, Boland CR and Goel A: Fecal MicroRNAs as novel
biomarkers for colon cancer screening. Cancer Epidemiol Biomarkers
Prev. 19:1766–1774. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
196
|
Bastaminejad S, Taherikalani M, Ghanbari
R, Akbari A, Shabab N and Saidijam M: Investigation of MicroRNA-21
expression levels in serum and stool as a potential non-invasive
biomarker for diagnosis of colorectal cancer. Iran Biomed J.
21:106–113. 2017. View Article : Google Scholar :
|
|
197
|
Liu X, Xu X, Pan B, He B, Chen X, Zeng K,
Xu M, Pan Y, Sun H, Xu T, et al: Circulating miR-1290 and miR-320d
as novel diagnostic biomarkers of human colorectal cancer. J
Cancer. 10:43–50. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
198
|
Eslamizadeh S, Heidari M, Agah S,
Faghihloo E, Ghazi H, Mirzaei A and Akbari A: The role of microRNA
signature as diagnostic biomarkers in different clinical stages of
colorectal cancer. Cell J. 20:220–230. 2018.PubMed/NCBI
|
|
199
|
Ng L, Wan TM, Man JH, Chow AK, Iyer D,
Chen G, Yau TC, Lo OS, Foo DC, Poon JT, et al: Identification of
serum miR-139-3p as a non-invasive biomarker for colorectal cancer.
Oncotarget. 8:27393–27400. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
200
|
Turchinovich A, Weiz L, Langheinz A and
Burwinkel B: Characterization of extracellular circulating
microRNA. Nucleic Acids Res. 39:7223–7233. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
201
|
Köberle V, Pleli T, Schmithals C, Augusto
Alonso E, Haupenthal J, Bönig H, Peveling-Oberhag J, Biondi RM,
Zeuzem S, Kronenberger B, et al: Differential stability of
cell-free circulating microRNAs: Implications for their utilization
as biomarkers. PLoS One. 8:e751842013. View Article : Google Scholar : PubMed/NCBI
|
|
202
|
Glinge C, Clauss S, Boddum K, Jabbari R,
Jabbari J, Risgaard B, Tomsits P, Hildebrand B, Kääb S, Wakili R,
et al: Stability of circulating blood-based microRNAs-pre-analytic
methodological considerations. PLoS One. 12:e01679692017.
View Article : Google Scholar
|
|
203
|
Carter JV, Galbraith NJ, Yang D, Burton
JF, Walker SP and Galandiuk S: Blood-based microRNAs as biomarkers
for the diagnosis of colorectal cancer: A systematic review and
meta-analysis. Br J Cancer. 116:762–774. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
204
|
Tan Y, Lin JJ, Yang X, Gou DM, Fu L, Li FR
and Yu XF: A panel of three plasma microRNAs for colorectal cancer
diagnosis. Cancer Epidemiol. 60:67–76. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
205
|
Guo S, Zhang J, Wang B, Zhang B, Wang X,
Huang L, Liu H and Jia B: A 5-serum miRNA panel for the early
detection of colorectal cancer. Onco Targets Ther. 11:2603–2614.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
206
|
Sohel MH: Extracellular/Circulating
MicroRNAs: Release Mechanisms, Functions and Challenges. Achievem.
Life Sci. 10:175–186. 2016. View Article : Google Scholar
|
|
207
|
Coleman D and Kuwada S: miRNA as a
biomarker for the early detection of colorectal cancer. Genes
(Basel). 15:3382024. View Article : Google Scholar : PubMed/NCBI
|
|
208
|
Wang ZY, Sun MH, Zhang Q, Li PF, Wang K
and Li XM: Advances in Point-of-Care Testing of microRNAs based on
portable instruments and visual detection. Biosensors (Basel).
13:7472023. View Article : Google Scholar : PubMed/NCBI
|
|
209
|
Dave VP, Ngo TA, Pernestig AK, Tilevik D,
Kant K, Nguyen T, Wolff A and Bang DD: MicroRNA amplification and
detection technologies: Opportunities and challenges for point of
care diagnostics. Lab Invest. 99:452–469. 2019. View Article : Google Scholar
|
|
210
|
Casado-Bedmar M and Viennois E: MicroRNA
and gut microbiota: Tiny but Mighty-novel insights into their
cross-talk in inflammatory bowel disease pathogenesis and
therapeutics. J Crohns Colitis. 16:992–1005. 2022. View Article : Google Scholar
|
|
211
|
Pourteymourfard Tabrizi Z and Jami MS:
Selection of suitable bioinformatic tools in micro-RNA research.
Gene Rep. 21:1008932020. View Article : Google Scholar
|
|
212
|
Minutentag IW, Seneda AL, Barros-Filhos
MC, de Carvalho M, Souza VGP, Hasimoto CN, Moraes MPT, Marchi FA,
Lam WL, Reis PP and Drigo SA: Discovery of novel miRNAs in
Colorectal Cancer: Potential biological roles and clinical utility.
Noncoding RNA. 9:652023.PubMed/NCBI
|
|
213
|
Pawelka D, Laczmanska I, Karpinski P,
Supplitt S, Witkiewicz W, Knychalski B, Pelak J, Zebrowska P and
Laczmanski L: Machine-learning-based analysis identifies miRNA
expression profile for diagnosis and prediction of colorectal
cancer: A preliminary study. Cancer Genomics Proteomics.
19:503–511. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
214
|
Kutluk H, Bruch R, Urban GA and Dincer C:
Impact of assay format on miRNA sensing: Electrochemical
microfluidic biosensor for miRNA-197 detection. Biosens
Bioelectron. 148:1118242020. View Article : Google Scholar
|
